Xenotransplantation

Franklin Hoke's article on Thomas Starzl's bold experiment in xenotransplantation (The Scientist, Sept. 28, 1992, page 1) is one of the most thoroughly researched I've found in a scientific journal. And yet it completely omits the fact that the subject of Starzl's experiment, a 35-year-old unidentified male, was HIV positive. Such an omission cannot have been unintentional. How does one specifically delineate the effects of drugs upon the immune system while conveniently ignoring the fact that

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Franklin Hoke's article on Thomas Starzl's bold experiment in xenotransplantation (The Scientist, Sept. 28, 1992, page 1) is one of the most thoroughly researched I've found in a scientific journal. And yet it completely omits the fact that the subject of Starzl's experiment, a 35-year-old unidentified male, was HIV positive. Such an omission cannot have been unintentional. How does one specifically delineate the effects of drugs upon the immune system while conveniently ignoring the fact that this particular immune system was compromised even before the experiment began?

Also, I think the article gave short shrift to Ingrid Newkirk's primary thesis, that is, how many more humans could have been helped with the monies spent for this debacle? If I accept published figures, it costs about $400 to provide prenatal care for expectant mothers. The Starzl experiment cost nearly $175,000, of which the patient paid not a dime. Well over 400 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Donald Barnes

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo